| # |
Company Name
|
Industry Name
|
Latest Price (Rs.)
|
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Inds. | Pharmaceuticals& Drugs | 1,654.7 |
-62.65 (-3.65%) |
Large Cap | 52,578 | 45.5 | 21.55 | 37.8 | 5.1 | |
| Cipla | Pharmaceuticals& Drugs | 1,229.6 |
5.35 (0.44%) |
Large Cap | 27,548 | 56.3 | 18.76 | 21.8 | 2.9 | |
| Torrent Pharma | Pharmaceuticals& Drugs | 4,157.3 |
64.15 (1.57%) |
Large Cap | 11,516 | 67.1 | 16.73 | 61 | 15.3 | |
| Divis Lab | Pharmaceuticals& Drugs | 6,119.5 |
161.85 (2.72%) |
Large Cap | 9,360 | 93.4 | 23.08 | 63.8 | 9.9 | |
| Apollo Hospital Ent. | Hospital &HealthcareServices | 7,514.7 |
34.45 (0.46%) |
Large Cap | 8,202 | 100.4 | 15.81 | 74.5 | 11.1 |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: